Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

VDD was associated with an increased risk of incident thyroid cancer (HR: 1.41; 95% CI: 1.32, 1.50), and this risk was attenuated among patients with vitamin D insufficiency (25[OH]D 20 to 30 ng/mL; HR: 1.27; 95% CI: 1.20, 1.34), demonstrating a dose-dependent relationship.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study

Source: Article title.

Adult patients aged ≥ 18 years with at least one recorded serum 25-hydroxyvitamin D [25(OH)D] measurement between January 1, 2010, and December 31, 2023, were eligible for inclusion.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study

Cohort study · Frontiers in Nutrition · 2026

Original publication title

Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study

Kuo-Chuan Hung; Chia-Li Kao; Ming Yew; Yi-Chen Lai; I-Wen Chen

Copyright © 2026 Hung, Kao, Yew, Lai and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Pre-diagnostic VDD was associated with increased thyroid cancer risk in a dose-dependent manner. These findings support further investigation of vitamin D status as a potentially modifiable risk factor for thyroid cancer.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D deficiency (VDD) has been implicated as a potential risk factor for thyroid cancer; however, existing evidence is derived primarily from case-control or cross-sectional studies. This study aimed to examine the association between pre-diagnostic VDD and the risk of incident thyroid cancer over a 10-year follow-up period.

Source: Background

Abstract: What methods does the paper describe?

This retrospective propensity score: matched cohort study used the TriNetX Global Collaborative Network. Adults aged ≥ 18 y with serum 25-hydroxyvitamin D [25(OH)D] measurements between 2010 and 2023 were classified as having VDD (<20 ng/mL) or vitamin D sufficiency (≥30 ng/mL). One-to-one propensity score matching was performed on demographics, comorbidities, thyroid-related disorders, laboratory values, and vitamin D supplementation. The primary outcome was incident thyroid cancer ascertained ≥ 180 day after the index date (landmark approach) over 10 y of follow-up. Positive (osteoporotic fracture) and negative (appendicitis, goiter) control outcomes and thyroid procedure utilization were evaluated to assess detection bias.

Source: Methods

Abstract: Results

After matching, 571,669 pairs were analyzed over a median follow-up of 6.8 y. VDD was associated with an increased risk of incident thyroid cancer (HR: 1.41; 95% CI: 1.32, 1.50), and this risk was attenuated among patients with vitamin D insufficiency (25[OH]D 20 to 30 ng/mL; HR: 1.27; 95% CI: 1.20, 1.34), demonstrating a dose-dependent relationship. Thyroid biopsy and ultrasonography utilization were lower in the VDD cohort (HR: 0.95), arguing against detection bias. The positive control outcome (osteoporotic fracture; HR: 1.53) confirmed the validity of the exposure classification, whereas the negative control (appendicitis; HR: 1.02) showed no association.

Findings were robust across all sensitivity and subgroup analyses.

Source: Results

Abstract: Conclusion

Pre-diagnostic VDD was associated with increased thyroid cancer risk in a dose-dependent manner. These findings support further investigation of vitamin D status as a potentially modifiable risk factor for thyroid cancer.

Source: Conclusion
Authors’ abstract

Background

Vitamin D deficiency (VDD) has been implicated as a potential risk factor for thyroid cancer; however, existing evidence is derived primarily from case-control or cross-sectional studies. This study aimed to examine the association between pre-diagnostic VDD and the risk of incident thyroid cancer over a 10-year follow-up period.

Methods

This retrospective propensity score: matched cohort study used the TriNetX Global Collaborative Network. Adults aged ≥ 18 y with serum 25-hydroxyvitamin D [25(OH)D] measurements between 2010 and 2023 were classified as having VDD (<20 ng/mL) or vitamin D sufficiency (≥30 ng/mL). One-to-one propensity score matching was performed on demographics, comorbidities, thyroid-related disorders, laboratory values, and vitamin D supplementation. The primary outcome was incident thyroid cancer ascertained ≥ 180 day after the index date (landmark approach) over 10 y of follow-up. Positive (osteoporotic fracture) and negative (appendicitis, goiter) control outcomes and thyroid procedure utilization were evaluated to assess detection bias.

Results

After matching, 571,669 pairs were analyzed over a median follow-up of 6.8 y. VDD was associated with an increased risk of incident thyroid cancer (HR: 1.41; 95% CI: 1.32, 1.50), and this risk was attenuated among patients with vitamin D insufficiency (25[OH]D 20 to 30 ng/mL; HR: 1.27; 95% CI: 1.20, 1.34), demonstrating a dose-dependent relationship. Thyroid biopsy and ultrasonography utilization were lower in the VDD cohort (HR: 0.95), arguing against detection bias. The positive control outcome (osteoporotic fracture; HR: 1.53) confirmed the validity of the exposure classification, whereas the negative control (appendicitis; HR: 1.02) showed no association.

Findings were robust across all sensitivity and subgroup analyses.

Conclusion

Pre-diagnostic VDD was associated with increased thyroid cancer risk in a dose-dependent manner. These findings support further investigation of vitamin D status as a potentially modifiable risk factor for thyroid cancer.

Publication and source details

Original title: Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study

Kuo-Chuan Hung; Chia-Li Kao; Ming Yew; Yi-Chen Lai; I-Wen Chen

Frontiers in Nutrition · 2026

* Correspondence: I-Wen Chen, cheniwena60912@gmail.comCopyright © 2026 Hung, Kao, Yew, Lai and Chen.2026Hung, Kao, Yew, Lai and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:23:01.276257+00:00

DOI: 10.3389/fnut.2026.1817123 · PMC13138976